Pak Kaitlynne Y, Tang Dennis M, Sreenath Satyan B, Ito Christopher J, Senior Brent A, Lam Kent K, Higgins Thomas S, Hur Kevin, Tam Benjamin, Khalid Ayesha N, Wu Arthur W
Division of Otolaryngology-Head & Neck Surgery Cedars-Sinai Medical Center Los Angeles USA.
Department of Otolaryngology-Head & Neck Surgery Indiana University Bloomington USA.
Laryngoscope Investig Otolaryngol. 2024 Jul 16;9(4):e1299. doi: 10.1002/lio2.1299. eCollection 2024 Aug.
A novel bioresorbable agent on the market is PuraGel® (3-D Matrix, Tokyo, Japan), a RADA-16 product that acts as a synthetic hemostatic and space-filling gel that promotes wound healing and prevents adhesion formation. Given the reported benefits of accelerated wound healing and scar tissue prevention, there are multiple otolaryngologic applications where RADA-16 might improve outcomes. Our study highlights current utilization and associated post-operative complications with this product.
市场上一种新型的可生物吸收剂是PuraGel®(3-D Matrix,东京,日本),它是一种RADA-16产品,作为一种合成的止血和填充空间的凝胶,可促进伤口愈合并防止粘连形成。鉴于有报道称其具有加速伤口愈合和预防瘢痕组织形成的益处,在多个耳鼻喉科应用中,RADA-16可能会改善治疗效果。我们的研究强调了该产品目前的使用情况及相关的术后并发症。